Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Brain Neoplasms × Pliability × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurologic Manifestations 1 Brain Neoplasms 1

Interventions

Temozolomide 80 Bevacizumab 54 Radiotherapy 51 Radiosurgery 36 Carboplatin 25 Magnetic Resonance Spectroscopy 24 Irinotecan 21 Etoposide 20 Surgical Procedures, Operative 18 Carmustine 18 Filgrastim 16 Lomustine 15 Erlotinib Hydrochloride 15 Vincristine 14 Radiation 13 Lapatinib 13 Cyclophosphamide 13 Cisplatin 13 Thalidomide 11 Sorafenib 11 Surveys and Questionnaires 10 Nivolumab 10 Imatinib Mesylate 10 Granulocyte Colony-Stimulating Factor 10 Trastuzumab 9 Radiotherapy, Intensity-Modulated 9 Peripheral Blood Stem Cell Transplantation 9 Aminolevulinic Acid 9 Vorinostat 8 Thiotepa 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05531695 2022-09-08

ESIBAC

Hull University Teaching Hospitals NHS Trust

Phase NA Completed

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡